pep-05350 v1 CC-BY-SA-4.0
Palustrin-3a cancer-fighting peptide
A short protein fragment studied in the lab for its ability to kill or slow the growth of cancer cells; experimental, not yet an approved drug.
status
Someone proposed this peptide.
A researcher, an agent, or an algorithm wrote down the sequence and picked a target to hit.
A computer predicted how the peptide binds to its target.
An AI model like OpenFold3 or AlphaFold built a 3D structure and scored how well it fits the binding site.
Someone else ran the same prediction and got the same result.
A second contributor repeated the computation on their own hardware and the scores matched.
The peptide was actually made in a lab.
A chemistry service or a researcher ordered the sequence, it was manufactured, and mass spectrometry confirmed the right molecule was produced.
The peptide was tested on its target in a lab.
A binding or activity measurement confirmed that it actually does what the computer predicted — or didn't.
prediction metrics
ipTM0.000
pTM0.461
avg pLDDT64.2
ranking score0.606
STRUCTURE · PEP-05350 × ANTICANCER
ranking0.606
target interface 4.5Å peptide drag rotate · ctrl+scroll zoom · right-click pan
sequence
15101520253035404548
GIFPKIIGKGIKTGIV NGIKSLVKGVGMKVFK AGLNNIGNTGCNEDEC
in the news
details
▸full evidence table1 metrics
| metric | value | tool |
|---|---|---|
| ranking score | 0.6056109070777893 | boltz-2 |
▸3-letter notation
Gly-Ile-Phe-Pro-Lys-Ile-Ile-Gly-Lys-Gly-Ile-Lys-Thr-Gly-Ile-Val-Asn-Gly-Ile-Lys-Ser-Leu-Val-Lys-Gly-Val-Gly-Met-Lys-Val-Phe-Lys-Ala-Gly-Leu-Asn-Asn-Ile-Gly-Asn-Thr-Gly-Cys-Asn-Glu-Asp-Glu-Cys
▸recipeboltz-2 2.2.1
| parameter | value |
|---|---|
| model | boltz-2 2.2.1 |
| weights | — |
| hardware | vast_v100_32gb |
| mlx version | — |
| python | — |
| random seed | 1 |
| msa strategy | none_monomer |
| runtime | — |
| predicted by | — |
| predicted at | 2026-05-23 |
▸citationbibtex
peptidemodel (2026). Palustrin-3a cancer-fighting peptide (pep-05350, v1). PeptideModel. https://peptidemodel.com/card/pep-05350
@peptide{pep05350,
sequence = {GIFPKIIGKGIKTGIVNGIKSLVKGVGMKVFKAGLNNIGNTGCNEDEC},
target = {anticancer},
author = {peptidemodel},
year = {2026},
status = {computed}
} references
discussion
sign in to comment